Shockwaves, the P-Shot—do these treatments really work for erectile dysfunction?

Summary

In a brief, one‑minute presentation, Dr. Fantus from the University of Kansas Urology Department outlines the mechanistic rationale for low‑intensity shockwave therapy (Li‑SWT) and platelet‑rich plasma (PRP) injections, commonly marketed as the "P‑Shot," in the context of erectile dysfunction (ED). He explains that Li‑SWT is intended to stimulate neovascularization and improve penile blood flow, while the P‑Shot aims to enhance tissue healing through growth factor release. The physician reviews the existing clinical literature, noting that most studies on Li‑SWT are small, heterogenous, and often lack long‑term follow‑up, resulting in mixed conclusions about efficacy. For PRP, he points out that high‑quality randomized controlled trials are scarce, and the procedure remains investigational in most guidelines. He emphasizes that both modalities are considered experimental or adjunctive, and that standard first‑line therapies—such as phosphodiesterase‑5 inhibitors—remain the evidence‑based cornerstone of ED management. The video also touches on the regulatory status, mentioning that the FDA has not approved either treatment for erectile dysfunction. Dr. Fantus advises patients to discuss these options with a qualified urologist, consider the cost‑benefit profile, and be wary of clinics that promise guaranteed results. He underscores the importance of comprehensive evaluation for underlying health conditions that may contribute to ED before pursuing novel interventions. Overall, the segment aims to provide a balanced, evidence‑aware overview, encouraging viewers to adopt a cautious, informed approach when considering emerging ED therapies.

Key Takeaways

• ✓Low‑intensity shockwave therapy and the P‑Shot are marketed as ED treatments but lack robust, large‑scale clinical evidence.
• ✓Current research on shockwave therapy shows mixed results, with many studies limited by small sample sizes and short follow‑up.
• ✓PRP injections for ED are largely investigational, with few high‑quality trials supporting their use.
• ✓Standard ED treatments, such as PDE‑5 inhibitors, remain the first‑line, evidence‑based options.
• ✓Patients should consult a qualified urologist and weigh costs, potential benefits, and regulatory status before trying experimental therapies.

What to Be Careful About

• ⚠Both shockwave therapy and the P‑Shot are considered experimental; efficacy and safety are not fully established.
• ⚠The FDA has not approved these treatments specifically for erectile dysfunction.

Health Claims in This Video

Topics

Related reviews

• REVERSE Erectile Dysfunction Naturally!Dr. Eric Berg DC
• 7 Causes of Erectile Dysfunction You can Fix (ED 2026)KenDBerryMD
• Suffering from ED?!Rena Malik, M.D.